BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.

Autres langues Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Actions

688621

CNE100005139

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 06/06/2024			Varia. 5j.	Varia. 1 janv.
47,95 ^CNY	-2,80 %		-2,72 %	-31,25 %

25/04	Beijing Sun-Novo Pharmaceutical Research Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
26/02	Beijing Sun-Novo Pharmaceutical Research Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.(XSSC:688621) added to S&P Global BMI Index	18/09/23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.	04/09/23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches	16/05/23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Sun-Novo Pharma Unit Gets Drug Regulator's Certification for Desmopressin Injection	13/04/23
Sun-Novo Pharma Unit to Set Up 10 Million Joint Venture With Midea Pharma	12/04/23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. announced that it expects to receive CNY 1 billion in funding	11/04/23
Sun-Novo Pharma Logs 49.8% Jump in 2022 Profit	10/02/23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	09/02/23
Sun-Novo Pharmaceutical Purchases Azilsartan Tablets’ Marketing Rights For $5 Million	23/11/22
Beijing Sun-Novo Gets Regulatory Approval in China For Anti-Dermatitis Cream	22/11/22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. announced that it expects to receive CNY 1 billion in funding	07/11/22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. agreed to acquire Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership), Liu Yujing and other shareholders.	25/10/22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	09/08/22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.(SHSE:688621) added to Shanghai Stock Exchange Composite Index	21/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Actions

688621

CNE100005139

Autres langues

Filtres